Schwabe Pharmaceuticals Selects ACD/Labs for Analytical Data Handling and Knowledge Management

Deployment of ACD/Spectrus software provides an efficient, common software environment for data processing and analysis, helping scientists leverage analytical knowledge.

Toronto, Canada—ACD/Labs, an informatics company that develops and commercializes solutions in support of R&D, today announced that Willmar Schwabe Pharmaceuticals, a leading phytopharmaceuticals company, selected software on the ACD/Spectrus Platform to aid spectroscopic identification and characterization of natural products in addition to managing their analytical knowledge.

Schwabe scientists in Karlsruhe, Germany will be using an array of tools—ACD/NMR Workbook Suite, ACD/MS Workbook Suite, ACD/ChemAnalytical Workbook, ACD/NMR Predictors, and ACD/MS Fragmenter—to help interpret HPLC, LC/MS, GC/MS, and NMR data from various instruments in the vendor-agnostic Spectrus environment.

“ACD/Labs’ software allows us to manage our analytical work with the great ability to solve structures of natural products often without

< | >